124 related articles for article (PubMed ID: 10089021)
1. Suppressed neutrophil function as a risk factor for severe infection after cytotoxic chemotherapy in patients with acute nonlymphocytic leukemia.
Hübel K; Hegener K; Schnell R; Mansmann G; Oberhäuser F; Staib P; Diehl V; Engert A
Ann Hematol; 1999 Feb; 78(2):73-7. PubMed ID: 10089021
[TBL] [Abstract][Full Text] [Related]
2. A multicenter trial of cytarabine plus idarubicin or daunorubicin as induction therapy for adult nonlymphocytic leukemia.
Wiernik PH; Case DC; Periman PO; Arlin ZA; Weitberg AB; Ritch PS; Todd MB
Semin Oncol; 1989 Feb; 16(1 Suppl 2):25-9. PubMed ID: 2928807
[No Abstract] [Full Text] [Related]
3. Infectious Complications in Children With Acute Myeloid Leukemia and Down Syndrome: Analysis of the Prospective Multicenter Trial AML-BFM 2004.
Hassler A; Bochennek K; Gilfert J; Perner C; Schöning S; Creutzig U; Reinhardt D; Lehrnbecher T
Pediatr Blood Cancer; 2016 Jun; 63(6):1070-4. PubMed ID: 26814618
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of granulocyte and granulocyte-macrophage colony-stimulating factors in the induction treatment of adult acute lymphoblastic leukemia: a multicenter randomized study.
Thomas X; Boiron JM; Huguet F; Reman O; Sutton L; Turlure P; Garban F; Gardin C; Espinouse D; Boulat O; Lhéritier V; Fiere D;
Hematol J; 2004; 5(5):384-94. PubMed ID: 15448664
[TBL] [Abstract][Full Text] [Related]
5. Sequential pilot studies of intensive postremission chemotherapy for acute nonlymphocytic leukemia.
Petti MC; Avvisati G; Tafuri A; Meloni G; Amadori S; Mandelli F
Ann N Y Acad Sci; 1987; 511():436-41. PubMed ID: 3326472
[No Abstract] [Full Text] [Related]
6. Wernicke's Encephalopathy in an Acute Myeloid Leukemia Patient: A Case Study.
Maden M; Pamuk G; Çelik Y; Ünlü E
Turk J Haematol; 2016 Mar; 33(1):78-9. PubMed ID: 27020725
[No Abstract] [Full Text] [Related]
7. Comparison of neutropenia profiles in different treatment protocols for acute myeloid leukemia using the D-index.
Kawasaki Y; Kimura SI; Nakano H; Mashima K; Shirato Y; Kawaguchi SI; Toda Y; Ochi SI; Nagayama T; Minakata D; Yamasaki R; Morita K; Ashizawa M; Yamamoto C; Hatano K; Sato K; Oh I; Fujiwara SI; Ohmine K; Kako S; Muroi K; Kanda Y
Int J Hematol; 2019 Apr; 109(4):470-476. PubMed ID: 30684252
[TBL] [Abstract][Full Text] [Related]
8. Less toxicity by optimizing chemotherapy, but not by addition of granulocyte colony-stimulating factor in children and adolescents with acute myeloid leukemia: results of AML-BFM 98.
Creutzig U; Zimmermann M; Lehrnbecher T; Graf N; Hermann J; Niemeyer CM; Reiter A; Ritter J; Dworzak M; Stary J; Reinhardt D
J Clin Oncol; 2006 Sep; 24(27):4499-506. PubMed ID: 16983120
[TBL] [Abstract][Full Text] [Related]
9. Liposomal daunorubicin, fludarabine, and cytarabine (FLAD) as bridge therapy to stem cell transplant in relapsed and refractory acute leukemia.
De Astis E; Clavio M; Raiola AM; Ghiso A; Guolo F; Minetto P; Galaverna F; Miglino M; Di Grazia C; Ballerini F; Marani C; Pastori G; Mitscheunig L; Cruciani F; Lovera D; Varaldo R; Ghiggi C; Lemoli RM; Bacigalupo A; Gobbi M
Ann Hematol; 2014 Dec; 93(12):2011-8. PubMed ID: 24989345
[TBL] [Abstract][Full Text] [Related]
10. Acute myeloid leukemia in Manitoba. The consequences of standard "7 + 3" remission-induction therapy followed by high dose cytarabine postremission consolidation for myelosuppression, infectious morbidity, and outcome.
Bow EJ; Kilpatrick MG; Scott BA; Clinch JJ; Cheang MS
Cancer; 1994 Jul; 74(1):52-60. PubMed ID: 8004583
[TBL] [Abstract][Full Text] [Related]
11. (1-3)-β-D-Glucan serum increase and small-airway-invasive radiological findings as early signs of pulmonary aspergillosis in high-risk hematologic patients in the posaconazole era: preliminary observations.
Picardi M; Della Pepa R; Giordano C; Pugliese N; Mortaruolo C; Trastulli F; Grimaldi F; Zacheo I; Raimondo M; Sirignano C; Salvatore P; Pane F
Ann Hematol; 2019 Feb; 98(2):527-531. PubMed ID: 30033485
[No Abstract] [Full Text] [Related]
12. Selective discharge of patients with acute myeloid leukemia during chemotherapy-induced neutropenia.
Gillis S; Dann EJ; Rund D
Am J Hematol; 1996 Jan; 51(1):26-31. PubMed ID: 8571934
[TBL] [Abstract][Full Text] [Related]
13. [IDA-FLAG (idarubicin, fludarabine, high dosage cytarabine and G-CSF)--an effective therapy regimen in treatment of recurrent acute myelocytic leukemia in children and adolescents. Initial results of a pilot study].
Fleischhack G; Graf N; Hasan C; Ackermann M; Breu H; Zernikow B; Bode U
Klin Padiatr; 1996; 208(4):229-35. PubMed ID: 8926688
[TBL] [Abstract][Full Text] [Related]
14. Neutrophil recovery time and adverse side effects in acute leukemia patients treated with intensive chemotherapy and concomitant G or GM-CSF.
Alvarado Ibarra ML; Borbolla Escoboza JR; López-Hernández MA; González-Avante CM; FloresChapa JD; Trueba Christy E; Anaya Cuellar I
Rev Invest Clin; 1999; 51(2):77-80. PubMed ID: 10410585
[TBL] [Abstract][Full Text] [Related]
15. FLAIE (fludarabine, cytarabine, idarubicin, and etoposide), a four drug induction chemotherapy for adult acute myeloid leukemia: A single center experience.
Candoni A; Simeone E; Tiribelli M; Malagola M; Russo D; Fanin R
Am J Hematol; 2009 Oct; 84(10):690-2. PubMed ID: 19731308
[No Abstract] [Full Text] [Related]
16. Granulocyte colony-stimulating factor following chemotherapy in elderly patients with newly diagnosed acute myelogenous leukemia.
Maslak PG; Weiss MA; Berman E; Yao TJ; Tyson D; Golde DW; Scheinberg DA
Leukemia; 1996 Jan; 10(1):32-9. PubMed ID: 8558934
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of common salvage chemotherapy regimens in patients with refractory or relapsed acute myeloid leukemia: A retrospective cohort study.
Xu J; Lv TT; Zhou XF; Huang Y; Liu DD; Yuan GL
Medicine (Baltimore); 2018 Sep; 97(39):e12102. PubMed ID: 30278488
[TBL] [Abstract][Full Text] [Related]
18. [Effectiveness of empirical antibiotic therapy in the control of infections in patients with acute leukemia during severe neutropenia].
Hansz J; Woźny T; Bajko G; Drozdowska D
Pol Arch Med Wewn; 1992 Jun; 87(6):379-85. PubMed ID: 1408996
[TBL] [Abstract][Full Text] [Related]
19. [Treating patients with acute myeloid leukemias (AML) according to the protocol of the AML-01.10 Russian multicenter randomized trial: the coordinating center's results].
Parovichnikova EN; Troitskaia VV; Kliasova GA; Kuz'mina LA; Sokolov AN; Paramonova EV; Galstian GM; Kessel'man SA; Drokov MIu; Vasil'eva VA; Obukhova TN; Kulikov SM; Savchenko VG
Ter Arkh; 2014; 86(7):14-23. PubMed ID: 25314773
[TBL] [Abstract][Full Text] [Related]
20. Fulminant hepatic failure after high-dose cytosine arabinoside and mitoxantrone treatment for relapse of acute myelogenous leukaemia.
Nachbaur K; Dietze O; Herold M; Thaler J; Braunsteiner H; Vogel W
Eur J Haematol; 1992 Oct; 49(4):221-3. PubMed ID: 1464366
[No Abstract] [Full Text] [Related]
[Next] [New Search]